| advanced glycation end-products | AGEs |
| bone mineral density | BMD |
| bone morphogenetic proteins | BMPs |
| Camurati–Engelman Disease | CED |
| endoplasmic reticulum | ER |
| extracellular matrix | ECM |
| heat shock protein 47 | Hsp47 |
| latency-associated protein | LAP |
| lipoprotein receptor-related protein 5 | LRP 5 |
| Loeys–Dietz syndrome | LDS |
| lysyl hydroxylase 2 | LH2 |
| Marfan Syndrome | MFS |
| matrix metalloproteinases | MMPs |
| mitogen-activated protein kinase | MAPK |
| noncollagenous proteins | NCPs |
| osteocalcin | OC |
| osteogenesis imperfecta | OI |
| osteonectin | ON |
| osteopontin | OPN |
| osteoporosis-pseudoglioma syndrome | OPPG |
| osteoprotegerin | OPG |
| ovariectomized | OVX |
| parathyroid hormone | PTH |
| receptor activator of nuclear factor κβ ligand | RANKL |
| runt-related transcription factor 2 | Runx2 |
| single nucleotide polimorfism | SNP |
| transforming growth factor beta | TGF-β |
| tissue inhibitors of metalloproteinases | TIMPs |
| wingless-type mouse mammary tumor virus integration site family | Wnt |